Aisling R Caffrey
Overview
Explore the profile of Aisling R Caffrey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
815
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Caffrey A, Appaneal H, Lopes V, Lavoie T, Puzniak L, Zasowski E, et al.
Microbiol Spectr
. 2025 Mar;
:e0320924.
PMID: 40042306
Coronavirus disease 2019 (COVID-19) has complicated the management of acute respiratory infections and impacted antibiotic use. We assessed the relationship between nirmatrelvir/ritonavir (NMV/r) receipt and outpatient antibiotic prescribing among patients...
2.
Caffrey A, Appaneal H, Lopes V, Puzniak L, Zasowski E, Jodar L, et al.
Nat Commun
. 2024 Nov;
15(1):9490.
PMID: 39488521
Data evaluating effectiveness of XBB.1.5-adapted vaccines against JN.1-related endpoints are scarce. This nationwide test-negative case-control study within the US Veterans Affairs Healthcare System aims to estimate vaccine effectiveness (VE) of...
3.
Sine K, Lavoie T, Caffrey A, Lopes V, Dosa D, LaPlante K, et al.
Pharmacotherapy
. 2024 Mar;
44(4):308-318.
PMID: 38483080
Introduction: There are known disparities in the treatment of infectious diseases. However, disparities in treatment of complicated urinary tract infections (UTIs) are largely uninvestigated. Objectives: We characterized UTI treatment among...
4.
Caffrey A, Appaneal H, Lopes V, Riccobene T, LaPlante K
Am J Health Syst Pharm
. 2024 Feb;
81(12):509-520.
PMID: 38365226
Purpose: Multidrug-resistant (MDR) infections are challenging to treat due to underlying patient conditions, pathogen characteristics, and high antibiotic resistance rates. As newer antibiotic therapies come to market, limited data exist...
5.
Appaneal H, LaPlante K, Lopes V, Martin C, Puzniak L, Wiemken T, et al.
Infect Dis Ther
. 2024 Jan;
13(1):155-172.
PMID: 38217842
Introduction: Limited data exist regarding real-world utilization of nirmatrelvir/ritonavir. We identified predictors of nirmatrelvir/ritonavir use among Veterans Affairs (VA) outpatients nationally. Methods: We conducted a retrospective cohort study among outpatients...
6.
Liao J, Appaneal H, Menon A, Lopes V, LaPlante K, Caffrey A
Infect Dis Ther
. 2023 Jun;
12(7):1835-1848.
PMID: 37326931
Introduction: Gram-negative resistance is a well-acknowledged public health threat. Surveillance data can be used to monitor resistance trends and identify strategies to mitigate their threat. The objective of this study...
7.
Nigrovic L, Chun T, Vargas S, Caffrey A, Halperin J, Race J, et al.
BMJ Open
. 2023 Feb;
13(2):e071141.
PMID: 36854594
Introduction: Lyme disease is the most common vectorborne disease in the Northern hemisphere with more than 400 000 new cases in the USA annually. Lyme meningitis is an uncommon but...
8.
Appaneal H, Caffrey A, Lopes V, Dosa D, LaPlante K
Antibiotics (Basel)
. 2023 Feb;
12(2).
PMID: 36830137
Suboptimal antibiotic prescribing may be more common in patients living in rural versus urban areas due to various factors such as decreased access to care and diagnostic testing equipment. Prior...
9.
Gates D, Cohen S, Orr K, Caffrey A
J Pharm Pract
. 2023 Feb;
37(3):612-624.
PMID: 36724433
Pediatricians' offices are primary locations for pediatric influenza vaccination; however, pharmacists are also well-positioned as immunizers. Considering the current COVID-19 pandemic and Public Readiness and Emergency Preparedness (PREP) Act, pharmacists'...
10.
Appaneal H, Lopes V, LaPlante K, Caffrey A
J Med Microbiol
. 2022 Oct;
71(10).
PMID: 36306237
. is an important multidrug-resistant Gram-negative pathogen. While largely a hospital-acquired pathogen, there have been increasing reports of the pathogen in the community.. Trends in prevalence and resistance rates that...